Predictors of outcome in patients with implantable cardioverter defibrillators

被引:9
|
作者
Anvari, A
Gotsauner-Wolf, M
Türel, Z
Stix, G
Podesser, B
Mayer, C
Schuster, E
Schmidinger, H
机构
[1] Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria
[3] Univ Vienna, Inst Comp Sci, A-1090 Vienna, Austria
关键词
congestive heart failure; implantable cardioverter defibrillator; mortality; survival;
D O I
10.1159/000006841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study determined the impact of clinical characteristics on shock occurrence and survival in patients with implantable cardioverter-defibrillator (ICD). Methods and Results: During a follow-up of 27 +/- 18 months, the actuarial incidence of appropriate shocks in 200 consecutive patients was 18, 36 and 72% at 1, 3, and 5 years, respectively. Coronary artery disease was the only significant predictor for shock occurrence (relative risk 1.32, p = 0.03). The actuarial incidence of total mortality was 10, 17 and 33% at 1, 3, and 5 years, respectively. The most powerful predictors for total mortality were: New York Heart Association functional class (NYHA) III (relative risk 4.8, p = 0.001) and a history of congestive cardiac failure (relative risk 3.6, p = 0.01). Conclusion: During long-term follow-up, the majority of patients receive appropriate shocks. No strong predictors for shock occurrence can be identified from the data analyzed. A history of congestive cardiac failure and the NYHA III are the most powerful predictors for total mortality. These clinical factors may provide valuable criteria to identify patients who will benefit from the implantation of ICD.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [31] Implantable cardioverter-defibrillators in dialysis patients
    Mills, Mark T.
    [J]. BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 187 - 188
  • [32] Avoidance behaviors in patients with implantable cardioverter defibrillators
    Lemon, J
    Edelman, S
    Kirkness, A
    [J]. HEART & LUNG, 2004, 33 (03): : 176 - 182
  • [33] The use of implantable cardioverter defibrillators in pediatric patients
    V Campagnucci
    A Silva
    W Pereira
    A Peroni
    E Chamlian
    S Gandra
    A Scatolini
    U Lourenço
    F Silva
    L Rivetti
    [J]. Journal of Cardiothoracic Surgery, 8 (Suppl 1)
  • [34] MORE ON PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    EMBIL, JM
    GEDDES, JS
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) : 892 - 893
  • [35] Recommendations for driving of patients with implantable cardioverter defibrillators
    Jung, W
    Anderson, M
    Camm, AJ
    Jordaens, L
    Petch, MC
    Rosenqvist, M
    Santini, M
    Luderitz, B
    [J]. EUROPEAN HEART JOURNAL, 1997, 18 (08) : 1210 - 1219
  • [36] Peripartum management of patients with implantable cardioverter defibrillators
    Knowles, S.
    Greenlee, H.
    Bhatia, K.
    [J]. ANAESTHESIA, 2018, 73 : 20 - 20
  • [37] Predictors of long term survival among patients receiving implantable cardioverter-defibrillators
    Bhavnani, Sanjeev P.
    Sood, Nitesh
    Coleman, Craig I.
    Guertin, Danette
    Baker, William
    White, C. Michael
    Yarlagadda, Ravi
    Clyne, Christopher
    Kluger, Jeffrey
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A346 - A346
  • [38] Anxiety Disorders in Patients with Implantable Cardioverter Defibrillators: Frequency, Course, Predictors, and Patients' Requests for Treatment
    Lang, Saskia
    Becker, Ruediger
    Wilke, Stefanie
    Hartmann, Mechthild
    Herzog, Wolfgang
    Loewe, Bernd
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (01): : 35 - 47
  • [39] Ejection fraction and QRS width as predictors of event rates in patients with implantable cardioverter defibrillators
    Ashwath, ML
    Sogade, FO
    [J]. SOUTHERN MEDICAL JOURNAL, 2005, 98 (05) : 513 - 517
  • [40] Implantable cardioverter-defibrillators
    DiMarco, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19): : 1836 - 1847